Clinical Trials
64 trialsTICP
Hospices Civils de Lyon
AMPLE-3
The University of Western Australia
TraveraRTGx
Travera Inc
Metformin and Chemotherapy in Treating Patients With Stage III-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
University of Chicago
PMCF Study of the CE-marked Drainova® ArgentiC Catheter
ewimed GmbH
SWIFT
C. R. Bard
A Pilot Study Evaluating the Safety and Effectiveness of a New Pleural Catheter for the Medical Management of Symptomatic, Recurrent, Malignant Pleural Effusions
C. R. Bard
The Experiences of Patients Living With Malignant Pleural Effusions
Gloucestershire Hospitals NHS Foundation Trust
Cytological Examination of Malignant Pleural Effusion in Breast Cancer
Mansoura University Hospital
Thoracoscopic Talc Pleurodesis Versus Bleomycin -Tranxemic Acid Mixture Injection in Chest Tube in Malignant Pleural Effusion
Alexandria University
Quantitative C-Reactive Protein for Differentiating Tuberculous and Malignant Pleural Effusion: a Cross-Sectional Study
Maharajgunj Medical Campus
Management of Malignant Pleural Effusions Using an Indwelling Tunneled Pleural Catheter and Non-Vacuum Collection System
Washington University School of Medicine
OPTIMUM
Guy's and St Thomas' NHS Foundation Trust
Intraperitoneal vs Intravenous Chemotherapy Following Neoadjuvant Chemotherapy in Ovarian Cancer
Canadian Cancer Trials Group
MpeTK01
Candel Therapeutics, Inc.
Bleomycin, Doxycycline, or Talc in Treating Patients With Malignant Pleural Effusions
Eastern Cooperative Oncology Group
MY-IPC
Guy's and St Thomas' NHS Foundation Trust
ADD-Echo
University Hospital, Strasbourg, France
Intrapleural Instillation of the Nivolumab in Cancer Patients With Pleural Effusion.
Kidney Cancer Research Bureau
A Study to Compare the Efficacy and Safety of Intrapleural Doxycycline Versus Iodopovidone for Performing Pleurodesis in Malignant Pleural Effusion
Post Graduate Institute of Medical Education and Research, Chandigarh
Tunneled Pleural Catheter in Partially Entrapped Lung
Heidelberg University
Value of Additional Upfront Systematic Lung Ultrasound in the Workup of Patients With Unilateral Pleural Effusion
Naestved Hospital
A Phase I Study Evaluating SCB-313(Recombinant Human TRAIL-Trimer Fusion Protein) for the Treatment of Malignant Pleural Effusion
Sichuan Clover Biopharmaceuticals, Inc.
Study With SCB-313 (Recombinant Human TRAIL-Trimer Fusion Protein) for Treatment of Malignant Pleural Effusions
Clover Biopharmaceuticals, Ltd
Romidepsin and Erlotinib Hydrochloride in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
University of Texas Southwestern Medical Center
The Added Value of CT Scanning in Patients With an Unilateral Pleural Effusion
Naestved Hospital
The Value of PET-CT in Pleural Effusions
Naestved Hospital
Phase I Trial of Afatinib (BIBW 2992) and Dasatinib in Non-small Cell Lung Cancer (NSCLC)
H. Lee Moffitt Cancer Center and Research Institute
Respiratory Function of Dexmedetomidine in Patients Undergoing Pleuroscopy
Attikon Hospital
Intrapleural BG00001 in Treating Patients With Malignant Pleural Mesothelioma or Malignant Pleural Effusions
Abramson Cancer Center at Penn Medicine
Efficacy of Iodopovidone Versus Talc in Palliative Malignant Pleural Effusion
Chiang Mai University
Erlotinib Hydrochloride With or Without Carboplatin and Paclitaxel in Treating Patients With Stage III-IV Non-small Cell Lung Cancer
National Cancer Institute (NCI)
Intrapleural Bevacizumab Injection for Malignant Effusion in Lung Cancer
Guangzhou Medical University
Intrapleural Docetaxel Administration Using Medical Pleuroscopy in Malignant Effusion With Lung Cancer
Asan Medical Center
Prognostic Factors on Malignant Pleural Effusion
The University of Hong Kong
Using Thoracic Ultrasound to Predict Pleurodesis Success in Malignant Pleural Effusions: a Pilot Study
University of Oxford
AZD0530 in Treating Patients With Extensive Stage Small Cell Lung Cancer
National Cancer Institute (NCI)
A Quality of Life Study re Management of Malignant Pleural Effusions
University Health Network, Toronto
Imatinib Mesylate and Paclitaxel in Treating Older Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
University of Washington
The 'MADe IT' Clinical Trial: Molecular Analyses Directed Individualized Therapy for Advanced Non-Small Cell Lung Cancer
H. Lee Moffitt Cancer Center and Research Institute
Phase II Study of Docetaxel + ZD1839 in Elderly Patients With Non-Small Cell Lung Cancer
H. Lee Moffitt Cancer Center and Research Institute
Single Agent Alimta in Poor Performance Status in Non-small Cell Lung Cancer
M.D. Anderson Cancer Center
FDG-Labeled PET Scan in Planning Chemotherapy in Treating Patients With Stage IIIB or IV Non-Small Cell Lung Cancer
University of Washington
A Prospective, Randomized Controlled Trial for a Rapid Pleurodesis Protocol for the Management of Pleural Effusions
Singapore General Hospital
Standard Chest Tube Compared With a Small Catheter in Treating Malignant Pleural Effusion in Patients With Cancer
Alliance for Clinical Trials in Oncology
Talc in Treating Patients With Malignant Pleural Effusion
Alliance for Clinical Trials in Oncology
Pleural Catheters Versus Thoracoscopic Pleurodesis
M.D. Anderson Cancer Center
BAY 43-9006 in Previously Untreated Patients With Non-Small Cell Lung Cancer (NSCLC)
M.D. Anderson Cancer Center
TIME-1
University of California, Davis
Decitabine in Treating Patients With Unresectable Lung or Esophageal Cancer or Malignant Mesothelioma of the Pleura
National Cancer Institute (NCI)